Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€142.00
13.12.20
€170.00
13.12.21
9.00%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
skatcup 
13.12.20 100%
buy
Ebix Inc.

Start price
Target price
Perf. (%)
€30.20
13.12.20
€35.00
13.12.21
-12.98%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
skatcup 
13.12.20 60%
sell
E.ON SE

Start price
Target price
Perf. (%)
€8.97
13.12.20
-
-0.76%
14.12.20

Could be worthwhile Investment >10% per year
phonebroker 
13.12.20 50%
sell
SLM Solutions Group AG

Start price
Target price
Perf. (%)
€15.50
13.12.20
-
13.12.21
5.42%
14.12.21

overvalued
Revenue decline/stagnation expected
EBIT decline/stagnation expected
kostojunior 
13.12.20 50%
sell
United Labels

Start price
Target price
Perf. (%)
€0.92
13.12.20
-
13.12.21
180.43%
14.12.21

Probably not worthwhile Investment
High risks for its business
Growths much slower than the competition
Below average Management
kostojunior 
13.12.20 50%
sell
Ming Le Sports AG

Start price
Target price
Perf. (%)
€1.27
13.12.20
€1.00
13.12.21
77.95%
03.04.21

Top 10 in its market
Future proof or reliable business model
Good rating
High risks for its business
kostojunior 
13.12.20 50%
sell
Voltabox

Start price
Target price
Perf. (%)
€3.80
13.12.20
-
13.12.21
-55.21%
14.12.21

Probably not worthwhile Investment
Bad rating
High risks for its business
Growths much slower than the competition
kostojunior 
13.12.20 0%
sell
Curis Inc.

Start price
Target price
Perf. (%)
€6.35
13.12.20
-
13.12.21
37.01%
16.02.21

Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand
tinelchen 
13.12.20 50%
sell
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.66
13.12.20
-
13.12.21
143.95%
16.02.21

Probably not worthwhile Investment
Significant cyclical dependencies
tinelchen 
13.12.20 50%
buy
Up Fintech Holding Ltd.

Start price
Target price
Perf. (%)
€4.74
13.12.20
€28.00
23.10.24
-18.57%
06.01.22

Subdi 
13.12.20 70%
buy
Cisco Systems Inc.

Start price
Target price
Perf. (%)
€36.70
12.12.20
-
12.12.21
6.27%
15.02.21

Fair valuation
High dividend yield expected
Higher risks for its business
ElectricPlayer 
12.12.20 50%
sell
Verrica Pharmaceuticals

Start price
Target price
Perf. (%)
€8.75
12.12.20
-
12.12.21
-2.29%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 50%
sell
Inseego Corp.

Start price
Target price
Perf. (%)
€12.26
12.12.20
-
12.12.21
-54.63%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 50%
sell
PhaseBio Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.60
12.12.20
-
12.12.21
-42.22%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 50%
sell
Tesla Inc

Start price
Target price
Perf. (%)
€166.97
12.12.20
€183.33
12.12.21
80.18%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 80%
sell
NIO Inc. ADR

Start price
Target price
Perf. (%)
€34.20
12.12.20
-
12.12.21
1.75%
15.12.20

Innovative
EBIT growth >5% per year expected
Top 10 in its market
Known brand
Traumtanz 
12.12.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Mercadolibre Inc

Start price
Target price
Perf. (%)
€1,335.8
12.12.20
-
12.12.21
6.06%
09.01.21

Could be worthwhile Investment >10% per year
Some uniques
Medium risks for its business
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Harmony Gold Mining

Start price
Target price
Perf. (%)
€3.42
12.12.20
€8.50
12.12.21
2.92%
22.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
synergy1 
12.12.20 50%
buy
Borgwarner Inc.

Start price
Target price
Perf. (%)
€30.40
12.12.20
-
12.12.21
21.71%
14.09.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Commando 
12.12.20 50%
buy
Palantir Technologies Inc.

Start price
Target price
Perf. (%)
€23.00
12.12.20
-
12.12.21
-6.09%
11.03.21

Could be worthwhile Investment >10% per year
Savour 
12.12.20 50%
buy
Formycon AG

Start price
Target price
Perf. (%)
€65.20
12.12.20
-
12.12.21
-7.06%
11.03.21

Could be worthwhile Investment >10% per year
Savour 
12.12.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
-
12.12.21
17.84%
16.02.21

Higher risks for its business
Increased challenges to pay loans and raise capital
SpringheelJack 
12.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
FXX 
12.12.20 50%
buy
Deutsche Lufthansa AG

Start price
Target price
Perf. (%)
€9.35
12.12.20
-
12.12.21
18.32%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
FXX 
12.12.20 50%